2026年6月托福机经套卷(第1套) - Read an Academic Passage Q3

Diagnostic Tools: Current Challenges and Innovations Diagnostic methodologies in clinical laboratory sciences are undergoing significant shifts. Traditional methods, such as blood tests and imaging techniques, have been standard for decades. However, emerging technologies like liquid biopsies (highly specialized forms of blood testing) and wearable devices are reshaping diagnostics by offering the potential for earlier and more continuous disease detection, though their complexity demands careful evaluation. Tumors release cells and DNA fragments into the bloodstream, which liquid biopsies can detect through a simple blood draw—eliminating the need for surgical tissue sampling while still enabling the monitoring of tumor progression and genetic mutations. Yet, this innovative technique has drawbacks such as false positives, which can lead to unnecessary medical interventions. Meanwhile, wearable devices provide continuous monitoring of vital signs, supplying real-time data to clinicians. The integration of such devices into healthcare systems introduces challenges related to managing vast amounts of patient data and ensuring the reliability of the collected information. The potential of these technologies is undeniable, but they are not without hurdles. Liquid biopsies and wearable devices illustrate the intersection of innovation and practicality in diagnostics. As they evolve, they present opportunities to redefine disease management, although rigorous validation is essential for clinical integration.